News Landos Biopharma, Inc.

Equities

LABP

US5150692011

Real-time Estimate Cboe BZX Other stock markets 12:16:33 2024-05-15 pm EDT			5-day change	1st Jan Change
22.4 ^USD	-0.22%		+0.65%	+510.66%

May. 09	Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	North American Morning Briefing : Stocks Seen -2-	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP	May. 11	BU
Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie	Apr. 16	PR
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
HC Wainwright Downgrades Landos Biopharma to Neutral From Buy	Apr. 01	MT
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP	Mar. 27	BU
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Landos Biopharma, Inc - LABP	Mar. 26	PR
Deals of the day-Mergers and acquisitions	Mar. 25	RE
Sector Update: Health Care Stocks Decline Late Afternoon	Mar. 25	MT
INVESTIGATION ALERT: Halper Sadeh LLC Investigates LABP, FUSN, KNTE	Mar. 25	PR
Top Midday Gainers	Mar. 25	MT
Sector Update: Health Care Stocks Softer in Afternoon Trading	Mar. 25	MT
Shareholder Alert: Ademi LLP investigates whether Landos Biopharma, Inc. has obtained a Fair Price in its transaction with AbbVie	Mar. 25	PR
LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders	Mar. 25	BU
AbbVie to Acquire Landos Biopharma For About $137.5 Million; Landos Shares Jump	Mar. 25	MT
Landos Biopharma Shares Surge 178% on Takeover Deal With AbbVie	Mar. 25	DJ
AbbVie in Deal to Acquire Landos Biopharma for $137.5 Million	Mar. 25	DJ
AbbVie to Acquire Landos Biopharma for About $137.5 Million	Mar. 25	MT
AbbVie to Acquire Landos Biopharma for About $137.5 Million	Mar. 25	MT
AbbVie to buy Landos to expand pipeline of immunity-related illnesses	Mar. 25	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Landos Biopharma, Inc.

Equities

LABP

US5150692011

Summary

Filters